|
|
||||||||
Departments of Nuclear Medicine and Cardiology, University Hospital, Free University of Brussels (VUB), Brussels, Belgium
Correspondence: For correspondence or reprints contact: Philippe R. Franken, Department of Nuclear Medicine, University Hospital, Laarbeeklaan 101, B-1090, Bussels, Belgium.
ABSTRACT
Iodine-123-free fatty acid analogs, such as beta-methyliodophenylpentadecanoic acid (BMIPP), allow for myocardial metabolic studies with SPECT. The goal of this investigation was to determine whether BMIPP uptake can be used to differentiate viable myocardium from scar tissue soon after coronary thrombolysis for acute myocardial infarction. Methods: BMIPP and 99mTc-sestamibi (MIBI) myocardial distribution after injection at rest were analyzed in 22 patients 4 to 10 days after coronary thrombolysis. The relative uptake of the two tracers was compared on a segmental basis to the regional wall motion and to the inotropic reserve assessed by two-dimensional echocardiography and low-dose dobutamine stimulation. Results: Three segmental patterns were identified in the infarct-related coronary artery territory. Segments with normal BMIPP and MIBI uptake showed normal wall motion. Segments with more reduced BMIPP uptake than MIBI uptake (mismatching) showed either normal wall motion or demonstrated inotropic reserve during dobutamine stimulation. Segments with matched defects always showed abnormal wall motion and did not demonstrate inotropic reserve, regardless of the MIBI uptake. Conclusion: In patients with subacute myocardial infarction, combined imaging of BMIPP and MIBI at rest might be more sensitive than MIBI or wall motion at rest alone to demonstrate myocardial areas that have been acutely ischemic. Mismatching is due to more severely depressed fatty acid metabolism than expected on the basis of the flow and is indicative of jeopardized, but viable myocardium. In dysfunctional segments, mismatching may correspond either to stunned or to hibernating myocardium. Matched defects are associated with scar tissue.
Key Words: BMIPP technetium-99m-sestamibi myocardial viability coronary thrombolysis
This article has been cited by other articles:
![]() |
N. Igarashi, T. Nozawa, N. Fujii, B.-i. Kato, M. Nonomura, A. Matsuki, T. Nakadate, A. Igawa, H. Asanoi, M. Inoue, et al. Evaluation of Fatty Acid Metabolism in Hearts After Ischemia-Reperfusion Injury Using a Dual-Isotope Autoradiographic Approach and Tissue Assay for Metabolites of Tracer J. Nucl. Med., January 1, 2005; 46(1): 160 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawai, E. Tsukamoto, Y. Nozaki, K. Morita, M. Sakurai, and N. Tamaki Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1888 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Richter, S. Fischer, N. Ernst, and D. L. Munz Extraction of Long-Chain Fatty Acids in Isolated Rat Heart During Acute Low-Flow Ischemia J. Nucl. Med., July 1, 2001; 42(7): 1101 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morimoto, H. Tomoda, M. Yoshitake, N. Aoki, S. Handa, and Y. Suzuki Prediction of Coronary Artery Lesions in Unstable Angina by Iodine 123 Beta-Methyl Iodophenyl Pentadecanoic Acid (BMIPP), a Fatty Acid Analogue, Single Photon Emission Computed Tomography at Rest Angiology, August 1, 1999; 50(8): 639 - 648. [Abstract] [PDF] |
||||
![]() |
Y Yazaki, M Isobe, W Takahashi, H Kitabayashi, O Nishiyama, M Sekiguchi, and T Takemura Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course Heart, February 1, 1999; 81(2): 153 - 159. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |